Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers

by | Sep 18, 2025 | Clinical Trials | 0 comments

​ Conditions: Healthy

Interventions: Drug: JLP-2302; Drug: JP-1366

Sponsors: Onconic Therapeutics Inc.

Completed Conditions: Healthy
Interventions: Drug: JLP-2302; Drug: JP-1366
Sponsors: Onconic Therapeutics Inc.
Completed 

Submit a Comment

Your email address will not be published. Required fields are marked *